Report says that the CDC’s projected number is 14 times the average purchase
After the announcement that the CDC would be greatly increasing their purchases of adult flu vaccines, major manufacturers are increasing production in anticipation of a particularly pivotal flu season.
The Washington Post reported flu vaccine producers are planning to increase production by about 10 percent, making about 19 million more doses in comparison to last year, according to The Post report. Manufacturers are anticipating to produce about 189 million doses ahead of the flu season, compared to 170 million last fall.
“We want to take flu off the table, in every way possible, make flu a non-factor,” LJ Tan, chief strategy officer of the Immunization Action Coalition, told The Post.
Robert Redfield, director of the Centers for Disease Control and Prevention, told The Post that the agency plans to buy 7 million flu vaccine doses for adults — 14 times more than the average purchase for a flu season.
The CDC initially requested $700 million from Congress to buy 50 million doses for adults but was ultimately denied, The Post reported. Officials told the publication that the agency has spent $100 million so far.
While it is possible to be infected with the flu and COVID-19 at the same time, it is not yet clear how the two conditions interact.
Only a third of Americans got a flu shot last year, but with the ongoing coronavirus pandemic likely overlapping with the upcoming flu season, government and health officials anticipate that more people might seek them out this fall, The Post reported.
Assistant Secretary for Health Brett Giroir reiterated the need for more flu vaccine doses to the House during a Tuesday hearing, recommending that the US has “enough flu vaccine to get everybody vaccinated this winter.”
SOURCES: Washington Post